Search Results
May 01, 2026, 04:21 ET Dreame Launches Three World-First Air and Environmental Products at DREAME NEXT, Marking North American Expansion
[1] 99.5% Hair Collection Rate: Dreame Lab Test Report No.: TL251105-001. In a 30m² test chamber with two cats, 2.582g collected vs 0.014g residual after 7 days in Pet Mode.
More news about: Dreame Technology
May 01, 2026, 04:05 ET ADC Therapeutics Makes Grants to New Employees Under Inducement Plan
conjugates (ADCs), today announced that the Company has made grants of options to purchase an aggregate of 49,400 of the Company's common shares to two new employees on May 1, 2026 (each, a "Grant").
More news about: ADC Therapeutics SA
May 01, 2026, 04:00 ET SynbioTech To Unveil Microbiome‑Based Platform for Women's Healthy Aging at Vitafoods Europe 2026
generated USD 38.30 billion in 2024 and is expected to reach USD 51.76 billion by 2030. For brands, the opportunity lies at the intersection of these two trends: women's healthy aging.Microbiome Solutions for the Many Dimensions of Women's AgingAs women's health broadens beyond single-function
More news about: SYNBIO TECH INC.
May 01, 2026, 03:30 ET TCL TECH 2025 Net Profit Surges 188.8%, Led by Strong Display Performance
company also secured rapid volume growth in the small- and medium-sized segments. In 2025, monitor panel shipments increased by 17%, securing the number two position globally, while gaming monitors remained firmly in first place worldwide. Laptop panel shipments surged 64%. Mobile phone panel shipments rose
More news about: TCL
May 01, 2026, 03:24 ET TCL TECH 2025 Net Profit Surges 188.8%, Led by Strong Display Performance
company also secured rapid volume growth in the small- and medium-sized segments. In 2025, monitor panel shipments increased by 17%, securing the number two position globally, while gaming monitors remained firmly in first place worldwide. Laptop panel shipments surged 64%. Mobile phone panel shipments rose
More news about: TCL
May 01, 2026, 02:30 ET Restore Vision Announces First-in-Human Clinical Interim Results for RV-001, a GPCR-Based Optogenetic Gene Therapy
Phase I/II clinical trial interim results, out to 168 days, from the two RV-001 dosing cohorts with advanced Retinitis Pigmentosa are presented at key May 2026 meetings: Eyecelerator and Retinal Therapeutics Innovation Summit.No dose-limiting toxicities (DLTs)
More news about: Restore Vision Inc.
May 01, 2026, 01:46 ET /C O R R E C T I O N -- Amity University Rajasthan/
Nottingham Trent University (UK), who had funded, and King Fahd University of Petroleum and Minerals (Saudi Arabia), has successfully concluded a landmark two-day international workshop titled "Adoption of the Inclusive Education Toolkit to Improve Accessibility in Indian Educational Institutes."
More news about: Amity University Rajasthan
May 01, 2026, 00:23 ET Kodiak Sciences to Present Pipeline Advances and KSI-101 Clinical Data, Including Results from a MESI Cohort in a Tertiary Care Uveitis Practice, at Upcoming Scientific Conferences
are no approved, locally administered biologics. Beyond KSI-101, currently in Phase 3 clinical development, Kodiak is advancing KSI-102 and KSI-103, two novel biologic therapies designed to address the complex cytokine interactions driving chronic inflammatory ocular diseases.3.
More news about: Kodiak Sciences Inc.
May 01, 2026, 00:14 ET Victory Square Technologies Reports Fiscal 2025 Results Highlighting Platform Scaling, Healthcare Infrastructure Growth and Portfolio Momentum
within a single compliant framework. Hydreight + Insu: Rails + Next-Generation PayloadTogether, Hydreight and Insu represent two complementary layers of the same opportunity.Hydreight provides the rails — the national infrastructure for compliant patient access, prescribing,
More news about: Victory Square Technologies Inc
Apr 30, 2026, 23:35 ET GIL Shareholder Alert: Gildan Activewear Inc. Class Action Lawsuit - Investors Should Contact Levi & Korsinsky
[email protected] or by telephone at (212) 363-7500.ABOUT THE FIRM -- For over two decades, Levi & Korsinsky has represented shareholders in securities class actions. Ranked in ISS Top 50 for seven consecutive years.Frequently
More news about: Levi & Korsinsky, LLP
Apr 30, 2026, 23:30 ET CRITICALLY-ACCLAIMED HITMAKER AMY ALLEN WINS 2026 ASCAP POP MUSIC SONGWRITER OF THE YEAR
Dean), "Messy" (Lola Young), "Mutt" (Leon Thomas), "Ordinary" (Alex Warren), "Pink Pony Club" (Chappell Roan) and more.Two-time Grammy-winning composer, singer, songwriter, producer and multi-instrumentalist Laufey accepts the prestigious ASCAP Creative Voice Award.
More news about: ASCAP - American Society of Composers, Authors and Publishers
Apr 30, 2026, 22:40 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Valneva SE - VALN
trial (NCT05477524) of its investigational 6-valent OspA-based Lyme disease vaccine candidate PF-07307405 (LB6V, formerly known as VLA15)". Although the two companies characterized the data as positive, the press release reported that the vaccine failed to meet its primary endpoint, citing a low incidence
More news about: Pomerantz LLP
Apr 30, 2026, 22:40 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ingram Micro Holding Corporation - INGM
action]On March 4, 2025, Ingram announced its fourth quarter and full year 2024 financial results. Among other items, Ingram disclosed that two distinct charges exceeding $20 million had a material impact on the business. These costs included more than $9 million attributed to "inventory write
More news about: Pomerantz LLP
Apr 30, 2026, 22:34 ET DREAME NEXT Concludes: Dreame Technology Caps Four-Day Silicon Valley Showcase with Science Forum and Ten-Year Vision
with wearable devices to deliver personalized dietary recommendations. The Dreame Air Conditioner X60 Series and Z Series redefine home climate with two world's first innovations—the world's first dual robotic arm air conditioner and the world's first fully embedded, integrated air conditioner—delivering
More news about: Dreame Technology
Apr 30, 2026, 22:05 ET FRONTERA ANNOUNCES RESULTS OF SPECIAL SHAREHOLDER MEETING
its next phase of growth and long‑term value creation."Each of the Arrangement and the Return of Capital required the approval of at least two thirds of the votes cast by shareholders present virtually or represented by proxy at the Meeting.At the Meeting, the special resolution approving
More news about: Frontera Energy Corporation
Apr 30, 2026, 21:45 ET INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Soleno Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines - SLNO
Commission that a patient had died after taking DCCR. On this news, Soleno's stock price fell $13.49 per share, or 19.21%, over the following two trading sessions, to close at $56.72 per share on September 11, 2025. Finally, on November 4, 2025, Soleno revealed during its quarterly earnings
More news about: Pomerantz LLP
Apr 30, 2026, 21:42 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zillow Group, Inc. - Z
recognition issues in Zillow's Flex model, in which the Company recognizes revenue when a lead is sent to an agent, despite the agent then having up to two years to close a deal. On this news, Zillow's stock price fell $2.85 per share, or 4.97%, to close at $54.49 per share on March 5, 2024. Then,
More news about: Pomerantz LLP
Apr 30, 2026, 21:20 ET Pomerantz Law Firm Announces the Filing of a Class Action Against ServBanc Holdco, Inc., ServBank, National Association, IF Bancorp, Inc., and its Board of Directors - IROQ
expected the Merger to close on March 12, 2026.On March 10, 2026, just over one month after IF Bancorp shareholders voted to approve the Merger and two days before it closed, IF Bancorp filed a Current Report on Form 8-K announcing it had entered into an agreement with ServBanc Holdco in connection with
More news about: Pomerantz LLP
Apr 30, 2026, 21:15 ET Pomerantz Law Firm Announces the Filing of a Class Action Against Regencell Bioscience Holdings Limited and Certain Officers - RGC
commercialization of traditional Chinese medicine ("TCM") for the treatment of attention-deficit/hyperactivity disorder ("ADHD") and autism spectrum disorder ("ASD")—two disorders generally considered incurable under current medical consensus. The Company asserts that while "[c]urrently available drugs and treatments
More news about: Pomerantz LLP
Apr 30, 2026, 20:56 ET Hydreight Reports Record Fiscal 2025 Results as VSDHOne Drives Rapid Growth and Platform Scale
VOLUME GROWTHOperational performance across the Company's core verticals continued to strengthen throughout 2025.The Company's first two verticals continued their historical growth in 2025, supported by alignment with broader market trends and the introduction of direct-to-consumer products
More news about: Hydreight Technologies Inc.
Apr 30, 2026, 20:55 ET Pomerantz Law Firm Announces the Filing of a Class Action Against Atara Biotherapeutics, Inc. and Certain Officers - ATRA
Application ("BLA") to the U.S. Food and Drug Administration ("FDA") for tabelecleucel as a monotherapy for the treatment of adult and pediatric patients two years of age and older with EBV+ PTLD who have received at least one prior therapy (the "tabelecleucel BLA"). The tabelecleucel BLA was purportedly supported
More news about: Pomerantz LLP
Apr 30, 2026, 19:42 ET INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Coty Inc. Of Class Action Lawsuit and Upcoming Deadlines - COTY
"operational discipline" in both Prestige and Consumer Beauty segments.On this news, Coty's stock price fell $0.77 per share, or 22.45%, over two trading sessions, to close at $2.66 per share on February 6, 2026.Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris,
More news about: Pomerantz LLP
Apr 30, 2026, 19:02 ET /C O R R E C T I O N -- Amgen/
(GPA)/Microscopic Polyangiitis (MPA)).DazodalibepDazodalibep is a fusion protein that inhibits CD40L.Two Phase 3 studies of dazodalibep in Sjögren's disease are underway. The first study is ongoing in patients with moderate-to-severe systemic disease activity.
More news about: Amgen
Apr 30, 2026, 18:30 ET Golden Corral® Accelerates Strategic Nationwide Growth with Six New Locations Underway
With two locations under construction in Knoxville, Tennessee and Kissimmee, Florida, existing franchisee growth is poised to play a significant role in the brand's
More news about: Golden Corral
Apr 30, 2026, 18:25 ET Sabio Holdings Inc. Announces Fiscal 2025 Results, Achieves Continued Growth and Advances Strategic Revenue Diversification
2025. Unless otherwise indicated, all amounts are expressed in U.S. dollars. "Despite economic uncertainties, including tariff-related impacts on two of our larger verticals, automotive and telecommunications, Sabio delivered double-digit top-line growth in its core business, supported by ongoing investment
More news about: Sabio Inc.